Savikalpa Sciences Logo

There’s no notification yet!

The Endocannabinoid System

The human endocannabinoid system consists of an extensive network of cannabinoid receptors (most notably the CB1 and CB2 receptors) found in the brain and throughout the body’s central nervous system, immune system, endocrine system and much more. Additionally, the body also produces its own endocannabinoids, of which Anandamide and 2-Arachidonoylglycerol (2-AG) and best known, and which are structurally similar to THC and CBD. While these 2 endocannabinoids currently receive the most research and attention, there are over 120 known endocannabinoids currently being studied.

01

Primary Cannabinoid Receptors

CB1

– Primarily located in the brain and spinal cord and play a role in nerve signalling. They are also found in the digestive tract, reproductive system, lungs, kidneys, liver, pituitary and thyroid glands, fat cells and muscle cells.

Primary Cannabinoid receptors - CB1 and CB2
This is caption example. Lorem ipsum dolor sit amet, consectetur adipiscing elit

CB2

– Primarily located in the immune system.

Primary Cannabinoid receptors - CB1 and CB2
This is caption example. Lorem ipsum dolor sit amet, consectetur adipiscing elit
02

Secondary Cannabinoid Receptors

Transient Receptor Potential Channels (TRP)

– Membrane proteins involved in the modulation of ion entry.

Peroxisome Proliferator Activated Receptors

– A group of nuclear hormone receptors. 

03

Regulatory functions

The endocannabinoid system is responsible for regulating many of the body’s natural functions including:

Pain & Inflammation

Research has indicated that cannabinoid receptors within the brain are capable of suppressing pain and inflammation. Cannabis medicine is currently being prescribed by doctors to treat chronic pain, nerve pain, as well as a variety of other sources of pain.

Appetite

The endocannabinoid system plays a role in regulating the body’s food intake. THC has been shown to increase appetite and regulated cannabis products already exist for the treatment of weight loss in patients undergoing treatment for cancer or HIV.

Sleep

Research has shown that anandamide, an endocannabinoid that shares structural similarities with THC, can affect sleep patterns. Due to the similar effects of THC and anandamide on the body, THC can be sedating at certain doses. 

Nausea

Research indicates that THC and other cannabinoids can block the signals in the body that result in nausea and vomiting. Many patients in regulated jurisdictions are already utilizing medical cannabis to reduce these symptoms in patients undergoing chemotherapy.

Anti-seizure

CBD has anti-seizure properties and is already being utilized as a treatment option for patients with certain types of uncontrolled epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome (LGS).

Mood management

Dosage depending, THC has been shown to produce a pleasant euphoria and feelings of relaxation in patients. However, if the dosage consumed is too high, it can result in feelings of anxiety/paranoia. Additionally, CBD has been noted to have anti-anxiety properties, and can reduce the potential of THC to induce anxiety/paranoia.

Memory & Learning

Areas of the brain responsible for regulating memory/learning contain a high concentration of cannabinoid receptors. This may explain the observed potentials of cannabinoids to be useful in the treatment of panic disorders, PTSD and other conditions related to memories/feelings of extreme fear.

While currently ongoing, there is still much research to be done to fully understand the endocannabinoid system and its role in maintaining homeostasis within the human body.